Stocksigma LogoStocksigma Logo

IOL Chemicals Announces ₹495 Cr Capex for Capacity Expansion and Business Diversification

IOL Chemicals and Pharmaceuticals Limited announced capex initiatives totaling ~₹495 Cr, funded entirely via internal accruals

IOL Chemicals Announces ₹495 Cr Capex for Capacity Expansion and Business Diversification

IOL Chemicals & Pharmaceuticals Ltd · Others (Uncategorized) · 09 Sept 2026, 8:03 pm

IOL Chemicals Announces ₹495 Cr Capex for Capacity Expansion and Business Diversification IOL Chemicals and Pharmaceuticals Limited announced capex initiatives totaling ~₹495 Cr, funded entirely via internal accruals. The company is expanding its backward-integrated Ibuprofen capacity at Barnala from 12,000 MTPA to 18,000 MTPA with a ₹350 Cr outlay, target commercialization by Dec'27. Additionally, it diversified into pharma formulations CDMO via a 1,500 million tablets/annum facility (₹110 Cr capex) with Hungary GMP approval, operational in Q3 FY'27. It also committed ₹35 Cr for a dedicated specialty chemicals tolling facility for a global client, commercializing in Q3 FY'27.

Original exchange filing (PDF)

More announcements from IOL Chemicals & Pharmaceuticals Ltd

All IOL Chemicals & Pharmaceuticals Ltd announcements